# Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.

> **NCT02107885** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 64 (actual)

## Conditions studied

- Safety
- Tolerability
- Pharmacokinetics

## Interventions

- **DRUG:** DS-1971
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02107885
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02107885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02107885, "Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02107885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*